What does it do? Inosine is a nucleoside, one of the basic
compounds comprising cells. It is a precursor to adenosine, an important energy molecule, and plays
many supportive roles in the body. Based upon anecdotal reports by Russian and Eastern
European athletes, inosine has been investigated for ergogenic (exercise boosting) effects.
However, controlled studies have concluded that inosine does not improve athletic performance and may even impair
it.1 2
Inosine is a precursor to uric acid, a compound that occurs naturally in the body. Uric
acid is believed to block the effect of a toxic free-radical compound (peroxynitrite) that may
play a role in the development of multiple sclerosis (MS).3 In an attempt to raise
uric acid levels, ten patients with MS were treated with inosine in amounts up to 3 grams per
day for 46 weeks. Three of the ten treated patients showed some evidence of improved function
and the others remained stable.4 Controlled studies are needed to confirm these
preliminary results.
Inosine has been used in
connection with the following conditions (refer to the individual
health concern for complete information):
Who is likely to be deficient? Inosine is not an essential
nutrient, so deficiencies do not occur.
How much is usually taken? Although a common amount of inosine
taken by athletes is 5,000–6,000 mg per day, little scientific evidence supports the use
of this supplement in any amount.
Are there any side effects or interactions? No side effects
have been reported with the use of inosine for two to five days in the limited research
available. However, unused inosine is converted by the body to uric acid, which may be
hazardous to people at risk for gout.
At the time of writing, there were no well-known drug interactions
with inosine.
References:
1. Starling RD, Trappe TA, Short KR, et al. Effect of inosine
supplementation on aerobic and anaerobic cycling performance. Med Sci Sports Ex
1996;28:1193–8.
2. Williams MH, Kreider RB, Hunter DW, et al. Effect of inosine
supplementation on 3-mile treadmill run performance and VO2 peak. Med Sci Sports
Exerc 1990;22:517–22.
3. Koprowski H, Spitsin SV, Hooper DC. Prospects for the treatment of
multiple sclerosis by raising serum levels of uric acid, a scavenger of peroxynitrite. Ann
Neurol 2001;49:139.
4. Koprowski H, Spitsin SV, Hooper DC. Prospects for the treatment of
multiple sclerosis by raising serum levels of uric acid, a scavenger of peroxynitrite. Ann
Neurol 2001;49:139.
Copyright © 2002 Healthnotes, Inc. All rights reserved.
www.healthnotes.com
Learn more about Healthnotes, the company.
Learn more about the authors of Healthnotes.
The information presented in Healthnotes is for informational
purposes only. It is based on scientific studies (human, animal, or in vitro),
clinical experience, or traditional usage as cited in each article. The results reported may
not necessarily occur in all individuals. For many of the conditions discussed, treatment with
prescription or over-the-counter medication is also available. Consult your doctor,
practitioner, and/or pharmacist for any health problem and before using any supplements or
before making any changes in prescribed medications. Information expires December 2003.
|